Maprotiline hydrochloride is a tetracyclic antidepressant primarily used in the treatment of major depressive disorders. It functions as a norepinephrine reuptake inhibitor, enhancing the levels of norepinephrine in the synaptic cleft, which is believed to contribute to its antidepressant effects. The substance appears as a white to off-white crystalline powder and is soluble in water, making it suitable for various pharmaceutical formulations. Its chemical structure includes a dibenzocycloheptene core, which is characteristic of its class. Maprotiline hydrochloride is typically administered orally and may have side effects such as sedation, dry mouth, and potential cardiovascular effects. Due to its pharmacological profile, it is important to monitor patients for any adverse reactions, especially in those with pre-existing conditions. As with all medications, it should be used under the guidance of a healthcare professional, considering potential interactions with other drugs and individual patient factors.

maprotiline hydrochloride

10347-81-6: 3-(9,10-ethanoanthracen-9(10H)-yl)-N-methylpropan-1-amine hydrochloride (1:1), 9,10-Dihydro-9-(3-methylaminopropyl)-9,10-ethanoanthracene hydrochloride, 9,10-Ethanoanthracene-9(10H)-propanamine, N-methyl-, hydrochloride, 9,10-Ethanoanthracene-9(10H)-propanamine, N-methyl-, hydrochloride (1:1), 9,10-Ethanoanthracene-9(10H)-propylamine, N-methyl-, hydrochloride, 9,10-Ethanoanthracene-9-propylamine, 9,10-dihydro-N-methyl-, hydrochloride, 9-[γ-(Methylamino)propyl]-9,10-dihydro-9,10-ethanoanthracene hydrochloride, Ba 34276, CIBA 34,276Ba, CIBA 34276 hydrochloride, Deprilept, Ladiomil, Ludiomil, Maprotiline HCL, Psymion

CAS 10347-81-6: maprotiline hydrochloride

Maprotiline.HCl

Ref: TR-LPM-MPT-1217-HC-50